Clinical trials
Recruiting Influenza, Human trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 12 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 8 |
| Emory University | 4 |
| GlaxoSmithKline | 3 |
| Washington University School of Medicine | 2 |
| AstraZeneca | 1 |
| Boston University | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| David Moss | 1 |
| Hoffmann-La Roche | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Influenza, Human | 42 |
| COVID-19 | 10 |
| Coronavirus Infections | 4 |
| Infections | 3 |
| Pneumonia | 3 |
| Respiratory Tract Infections | 3 |
| Communicable Diseases | 2 |
| Community-Acquired Pneumonia | 2 |
| Hematologic Neoplasms | 2 |
| Lung Diseases | 2 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.